NCT00344513View on ClinicalTrials.gov

Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

PHASE4CompletedINTERVENTIONAL

Enrollment

50,000

Participants

Timeline

Start Date

December 16, 2002

Study Completion Date

June 30, 2005

Conditions

Heart Failure, Congestive

Interventions

DRUG

Beta-blockers including Carvedilol

DRUG

ACE inhibitors

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY